Guest guest Posted May 20, 2011 Report Share Posted May 20, 2011 CLEAR: CLL Empirical Antibiotic Regimen - A phase II trial of broad spectrum antibiotic therapy for early stage, non- progressive chronic lymphocytic leukaemia without adverse prognostic factors This phase II trial is testing the use of antibiotics for patients with chronic lymphocytic leukaemia who have received no prior treatment. Patients will receive a short but intensive course of antibiotics, to help control the symptoms of their disease, early on. This national trial is being run by Dr Devereux at King's College London. Does anyone have any links to studies or research documents explaining the rationale? Or other studies/trials in this area that have been carried out. My limited understanding is that the trial is effectively investigating if infection drives CLL progression during the earlier stages of the disease?.. Nick (UK) Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.